Dung Le

Associate Professor

20022020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Dung Le is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 20 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Efficacy of pembrolizumab in patients with noncolorectal high microsatellite instability/ mismatch repair–deficient cancer: Results from the phase II KEYNOTE-158 study

Marabelle, A., Le, D. T., Ascierto, P. A., Di Giacomo, A. M., de Jesus-Acosta, A., Delord, J. P., Geva, R., Gottfried, M., Penel, N., Hansen, A. R., Piha-Paul, S. A., Doi, T., Gao, B., Chung, H. C., Lopez-Martin, J., Bang, Y. J., Frommer, R. S., Shah, M., Ghori, R., Joe, A. K. & 2 others, Pruitt, S. K. & Diaz, L. A., Jan 1 2020, In : Journal of Clinical Oncology. 38, 1, p. 1-10 10 p.

Research output: Contribution to journalArticle

  • A phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancer

    Yarchoan, M., Huang, C. Y., Zhu, Q., Ferguson, A. K., Durham, J. N., Anders, R. A., Thompson, E. D., Rozich, N. S., Thomas, D. L., Nauroth, J. M., Rodriguez, C., Osipov, A., De Jesus-Acosta, A., Le, D. T., Murphy, A. G., Laheru, D., Donehower, R. C., Jaffee, E. M., Zheng, L. & Azad, N. S., Jan 1 2019, (Accepted/In press) In : Cancer medicine.

    Research output: Contribution to journalArticle

    Open Access
  • Correction to: Developing real-world comparators for clinical trials in chemotherapy-refractory patients with gastric cancer or gastroesophageal junction cancer (Gastric Cancer, (2019), 10.1007/s10120-019-01008-9)

    Chau, I., Le, D. T., Ott, P. A., Korytowsky, B., Le, H., Le, T. K., Zhang, Y., Sanchez, T., Maglinte, G. A., Laurie, M., Abraham, P., Patel, D. & Shangguan, T., Jan 1 2019, (Accepted/In press) In : Gastric Cancer.

    Research output: Contribution to journalComment/debate

    Open Access
  • Developing real-world comparators for clinical trials in chemotherapy-refractory patients with gastric cancer or gastroesophageal junction cancer

    Chau, I., Le, D. T., Ott, P. A., Korytowsky, B., Le, H., Le, T. K., Zhang, Y., Sanchez, T., Maglinte, G. A., Laurie, M., Abraham, P., Patel, D. & Shangguan, T., Jan 1 2019, (Accepted/In press) In : Gastric Cancer.

    Research output: Contribution to journalArticle